"10.1371_journal.pone.0139893","plos one","2015-10-14T00:00:00Z","Vladimir A Morozov; Alexey V Morozov; Avi Rotem; Uriel Barkai; Stefan Bornstein; Joachim Denner","Robert Koch Institute, Berlin, Germany; Engelhardt Institute of Molecular Biology, RAS, Moscow, Russia; Beta-O2 Technologies Ltd., Rosh Haain, Israel; Center Internal Medicine, University Clinics Carl Gustav Carus, Technical University, Dresden, Germany","Conceived and designed the experiments: VAM JD. Performed the experiments: VAM AVM. Analyzed the data: VAM AVM JD. Contributed reagents/materials/analysis tools: VAM AVM AR UB SB JD. Wrote the paper: VAM UB JD. Critical reading of the manuscript: VAM JD AR UB SB. Compilation of the list of microorganisms which have to be tested: AR UB.","Authors AR and UB are affiliated with Beta-O2 Technologies, a biomedical company developing an implantable bio-artificial pancreas for treatment for diabetic patients. The device is designed for human transplants but could be used also with pig islet cells. This does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2015","10","Vladimir A Morozov","VAM",6,TRUE,2,2,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
